NCT05994495 - Utility and Acceptability of a Molecular Test in the Management of Sexually Transmitted Diseases in Uganda | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

January 30, 2025

Study Completion Date

March 30, 2025

Conditions

Sexually Transmitted Diseases

Interventions

DIAGNOSTIC_TEST

nuclear acid amplification tests

The NAAT test will be performed with Bosch Vivalytic STI test. It is a qualitative Polymerase Chain Reaction-based assay for simultaneous detection of 10 common sexually transmitted pathogens: Herpes simplex virus 1 (HSV 1)- Herpes simplex virus 2 (HSV 2)- Chlamydia trachomatis (CT) - Haemophilus ducreyi (HD)- Mycoplasma genitalium (MG) - Mycoplasma hominis (MH) - Neisseria gonorrhoeae (NG) - Treponema pallidum (TP)- Ureaplasma urealyticum (UU) - Trichomonas vaginalis (TV)

OTHER

Clinical Syndromic Approach

Physical examination

Trial Locations (1)

7051

Mulago National Referral Hospital, Kampala

All Listed Sponsors

collaborator

Societa' Italiana Di Malattie Infettive E Tropicali

OTHER

lead

Riccardo Serraino

OTHER